Biology

New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…
The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on DrugPatentWatch – Make Better Decisions.

The post New tentative approval for Watson Labs drug dienogest; estradiol valerate appeared first on Biotechblog.

Source link




Related posts

Both a Unique Motif at the C Terminus and an N-Terminal HEAT Repeat Contribute to G-Quadruplex Binding and Origin Regulation by the Rif1 Protein [Research Article]

Newsemia

Orphan Drug Patents: Concerns Raised by Payers and Policy Makers

Newsemia

Lovelace’s Novel Nucleoside LCMS Assay to Be Presented at 12th Workshop on Regulations in Bioanalysis

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy